Rat and Mouse Model Market Size, Share and Growth Outlook 2026: By Animal Type (Mice Models, Rat Models), By Model Type, By Technology, By Application, By End-User, Companies to 2034.
The global Rat and Mouse Model Market size is forecast to increase from $2.45 Billion in 2026 to $4.84 Billion in 2034 at a CAGR of 8.87% between 2026 and 2034.
The Rat and Mouse Model market report provides detailed analysis and outlook of Rat and Mouse Model segments including By Animal Type (Mice Models, Rat Models), By Model Type (Inbred Strains, Outbred Strains, Genetically Engineered Models (GEMs), Humanized Models), By Technology (CRISPR/Cas9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application (Oncology, Cardiovascular and Metabolic Disorders, Neurology and Psychiatry, Immunology and Infectious Diseases, Toxicology and Safety Assessment), By End-User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations (CROs), Academic and Research Institutes) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Rat and Mouse Model Industry Overview
Advanced Translational Research Demands Are Driving Innovation in Rat and Mouse Model Development
The rat and mouse model industry continues to evolve rapidly as pharmaceutical companies, biotechnology firms, and contract research organizations expand investments in translational research platforms capable of improving preclinical predictability and accelerating drug development timelines. Growing demand for precision medicine, immuno-oncology, radiopharmaceuticals, cell therapies, and antibody-drug conjugates is increasing reliance on highly characterized animal models that more accurately replicate human disease biology. Researchers are prioritizing sophisticated in vivo platforms, including humanized, genetically engineered, patient-derived, and spontaneous tumor models, to enhance pharmacokinetic, pharmacodynamic, efficacy, and resistance mechanism evaluation. This shift is driving substantial infrastructure expansion, model standardization efforts, and integration of computational technologies across the preclinical research ecosystem.
Humanized and Translational Animal Models Are Becoming Central to Next-Generation Drug Development
The increasing complexity of therapeutic pipelines has elevated the importance of advanced rodent models capable of supporting translational and precision medicine research. To address growing demand for predictive oncology models, Crown Bioscience, a JSR Life Sciences company, expanded its global infrastructure through the establishment of a dedicated Model Development Center in Kannapolis, North Carolina. The facility enhances capacity for producing highly characterized translational oncology models, including humanized mice, supporting the development of emerging therapeutic modalities such as antibody-drug conjugates and radiopharmaceuticals. The expansion reflects broader industry efforts to strengthen in vivo pharmacokinetic and pharmacodynamic modeling capabilities while improving the translational relevance of preclinical studies conducted across oncology and immunology research programs.
Digital Biology, Genetic Standardization, and Colony Monitoring Are Transforming Preclinical Research Models
Technological convergence between animal modeling, artificial intelligence, and colony management systems is reshaping the future of preclinical research. Research organizations are increasingly adopting advanced monitoring platforms and computational approaches to improve reproducibility, reduce biological variability, and enhance drug candidate selection. Charles River Laboratories has expanded deployment of its proprietary PathogenBinder® health monitoring platform throughout its Research Models and Services operations, enabling comprehensive colony surveillance without relying on traditional live sentinel animals. The system supports improved screening efficiency, minimizes genetic drift through International Genetic Standardization (IGS) protocols, and strengthens preclinical supply chain reliability. Simultaneously, Crown Bioscience's strategic collaboration with Turbine demonstrates the growing integration of artificial intelligence into translational research workflows, combining AI-driven cellular simulations with patient-derived and genetically humanized mouse models. By creating a continuous digital-to-biological validation framework, the partnership aims to improve prediction of drug efficacy and resistance mechanisms while reducing trial-and-error approaches in preclinical immuno-oncology development.
Rat and Mouse Model Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Rat and Mouse Model market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- The Jackson Laboratory, Charles River Laboratories International, Inc., Taconic Biosciences, Inc., Envigo RMS LLC, GemPharmatech Co., Ltd., Cyagen Biosciences, genOway, Crown Bioscience, Inc., InVivos Pte. Ltd., Janvier Labs. The Rat and Mouse Model market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Rat and Mouse Model industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Rat and Mouse Model industry include- The Jackson Laboratory, Charles River Laboratories International, Inc., Taconic Biosciences, Inc., Envigo RMS LLC, GemPharmatech Co., Ltd., Cyagen Biosciences, genOway, Crown Bioscience, Inc., InVivos Pte. Ltd., Janvier Labs. The Rat and Mouse Model market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Rat and Mouse Model Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Rat and Mouse Model market remains one of the strongest-performing segments in the country.
The US Rat and Mouse Model Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Rat and Mouse Model market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Rat and Mouse Model industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Rat and Mouse Model markets
Canada's strong Rat and Mouse Model sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Rat and Mouse Model market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Rat and Mouse Model Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Rat and Mouse Model market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Rat and Mouse Model population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Rat and Mouse Model industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Rat and Mouse Model market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Rat and Mouse Model sales through 2034
France Rat and Mouse Model companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Rat and Mouse Model Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Rat and Mouse Model distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Rat and Mouse Model Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Rat and Mouse Model market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Rat and Mouse Model industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Rat and Mouse Model industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Rat and Mouse Model Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Rat and Mouse Model market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Rat and Mouse Model market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Rat and Mouse Model Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Rat and Mouse Model Market Segmentation
By Animal Type
Mice Models
Rat Models
By Model Type
Inbred Strains
Outbred Strains
Genetically Engineered Models (GEMs)
Humanized Models
By Technology
CRISPR/Cas9
Microinjection
Embryonic Stem Cell Injection
Nuclear Transfer
By Application
Oncology
Cardiovascular and Metabolic Disorders
Neurology and Psychiatry
Immunology and Infectious Diseases
Toxicology and Safety Assessment
By End-User
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
Leading Companies in Rat and Mouse Model Industry (2026)
The Jackson Laboratory
Charles River Laboratories International, Inc.
Taconic Biosciences, Inc.
Envigo RMS LLC
GemPharmatech Co., Ltd.
Cyagen Biosciences
genOway
Crown Bioscience, Inc.
InVivos Pte. Ltd.
Janvier Labs
Countries Included
The Rat and Mouse Model market report provides detailed analysis and outlook of Rat and Mouse Model segments including By Animal Type (Mice Models, Rat Models), By Model Type (Inbred Strains, Outbred Strains, Genetically Engineered Models (GEMs), Humanized Models), By Technology (CRISPR/Cas9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application (Oncology, Cardiovascular and Metabolic Disorders, Neurology and Psychiatry, Immunology and Infectious Diseases, Toxicology and Safety Assessment), By End-User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations (CROs), Academic and Research Institutes) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Rat and Mouse Model Industry Overview
Advanced Translational Research Demands Are Driving Innovation in Rat and Mouse Model Development
The rat and mouse model industry continues to evolve rapidly as pharmaceutical companies, biotechnology firms, and contract research organizations expand investments in translational research platforms capable of improving preclinical predictability and accelerating drug development timelines. Growing demand for precision medicine, immuno-oncology, radiopharmaceuticals, cell therapies, and antibody-drug conjugates is increasing reliance on highly characterized animal models that more accurately replicate human disease biology. Researchers are prioritizing sophisticated in vivo platforms, including humanized, genetically engineered, patient-derived, and spontaneous tumor models, to enhance pharmacokinetic, pharmacodynamic, efficacy, and resistance mechanism evaluation. This shift is driving substantial infrastructure expansion, model standardization efforts, and integration of computational technologies across the preclinical research ecosystem.
Humanized and Translational Animal Models Are Becoming Central to Next-Generation Drug Development
The increasing complexity of therapeutic pipelines has elevated the importance of advanced rodent models capable of supporting translational and precision medicine research. To address growing demand for predictive oncology models, Crown Bioscience, a JSR Life Sciences company, expanded its global infrastructure through the establishment of a dedicated Model Development Center in Kannapolis, North Carolina. The facility enhances capacity for producing highly characterized translational oncology models, including humanized mice, supporting the development of emerging therapeutic modalities such as antibody-drug conjugates and radiopharmaceuticals. The expansion reflects broader industry efforts to strengthen in vivo pharmacokinetic and pharmacodynamic modeling capabilities while improving the translational relevance of preclinical studies conducted across oncology and immunology research programs.
Digital Biology, Genetic Standardization, and Colony Monitoring Are Transforming Preclinical Research Models
Technological convergence between animal modeling, artificial intelligence, and colony management systems is reshaping the future of preclinical research. Research organizations are increasingly adopting advanced monitoring platforms and computational approaches to improve reproducibility, reduce biological variability, and enhance drug candidate selection. Charles River Laboratories has expanded deployment of its proprietary PathogenBinder® health monitoring platform throughout its Research Models and Services operations, enabling comprehensive colony surveillance without relying on traditional live sentinel animals. The system supports improved screening efficiency, minimizes genetic drift through International Genetic Standardization (IGS) protocols, and strengthens preclinical supply chain reliability. Simultaneously, Crown Bioscience's strategic collaboration with Turbine demonstrates the growing integration of artificial intelligence into translational research workflows, combining AI-driven cellular simulations with patient-derived and genetically humanized mouse models. By creating a continuous digital-to-biological validation framework, the partnership aims to improve prediction of drug efficacy and resistance mechanisms while reducing trial-and-error approaches in preclinical immuno-oncology development.
Rat and Mouse Model Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Rat and Mouse Model market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- The Jackson Laboratory, Charles River Laboratories International, Inc., Taconic Biosciences, Inc., Envigo RMS LLC, GemPharmatech Co., Ltd., Cyagen Biosciences, genOway, Crown Bioscience, Inc., InVivos Pte. Ltd., Janvier Labs. The Rat and Mouse Model market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Rat and Mouse Model industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Rat and Mouse Model Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Rat and Mouse Model companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Rat and Mouse Model markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Rat and Mouse Model industry include- The Jackson Laboratory, Charles River Laboratories International, Inc., Taconic Biosciences, Inc., Envigo RMS LLC, GemPharmatech Co., Ltd., Cyagen Biosciences, genOway, Crown Bioscience, Inc., InVivos Pte. Ltd., Janvier Labs. The Rat and Mouse Model market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Rat and Mouse Model Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Rat and Mouse Model market remains one of the strongest-performing segments in the country.
The US Rat and Mouse Model Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Rat and Mouse Model market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Rat and Mouse Model industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Rat and Mouse Model markets
Canada's strong Rat and Mouse Model sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Rat and Mouse Model market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Rat and Mouse Model Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Rat and Mouse Model market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Rat and Mouse Model population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Rat and Mouse Model industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Rat and Mouse Model market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Rat and Mouse Model sales through 2034
France Rat and Mouse Model companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Rat and Mouse Model Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Rat and Mouse Model distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Rat and Mouse Model Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Rat and Mouse Model market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Rat and Mouse Model industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Rat and Mouse Model industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Rat and Mouse Model Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Rat and Mouse Model market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Rat and Mouse Model market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Rat and Mouse Model Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Rat and Mouse Model Market Segmentation
By Animal Type
Mice Models
Rat Models
By Model Type
Inbred Strains
Outbred Strains
Genetically Engineered Models (GEMs)
Humanized Models
By Technology
CRISPR/Cas9
Microinjection
Embryonic Stem Cell Injection
Nuclear Transfer
By Application
Oncology
Cardiovascular and Metabolic Disorders
Neurology and Psychiatry
Immunology and Infectious Diseases
Toxicology and Safety Assessment
By End-User
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
Leading Companies in Rat and Mouse Model Industry (2026)
The Jackson Laboratory
Charles River Laboratories International, Inc.
Taconic Biosciences, Inc.
Envigo RMS LLC
GemPharmatech Co., Ltd.
Cyagen Biosciences
genOway
Crown Bioscience, Inc.
InVivos Pte. Ltd.
Janvier Labs
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Rat and Mouse Model Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Rat and Mouse Model Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL RAT AND MOUSE MODEL MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Rat and Mouse Model Markets in 2026
3.2. Global Historic and Forecast Rat and Mouse Model Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Rat and Mouse Model Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Rat and Mouse Model Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Rat and Mouse Model Value Chain
CHAPTER 4- RAT AND MOUSE MODEL MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Rat and Mouse Model Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- RAT AND MOUSE MODEL MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Animal Type
Mice Models
Rat Models
By Model Type
Inbred Strains
Outbred Strains
Genetically Engineered Models (GEMs)
Humanized Models
By Technology
CRISPR/Cas9
Microinjection
Embryonic Stem Cell Injection
Nuclear Transfer
By Application
Oncology
Cardiovascular and Metabolic Disorders
Neurology and Psychiatry
Immunology and Infectious Diseases
Toxicology and Safety Assessment
By End-User
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA RAT AND MOUSE MODEL MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Rat and Mouse Model Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Rat and Mouse Model Market Trends and Growth Opportunities to 2034
7.5. North America Rat and Mouse Model Market Size Outlook by Type
7.6. North America Rat and Mouse Model Market Size Outlook by Application
7.7. North America Rat and Mouse Model Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Rat and Mouse Model Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Rat and Mouse Model Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Rat and Mouse Model Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Rat and Mouse Model Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Rat and Mouse Model Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Rat and Mouse Model Companies
CHAPTER 8- EUROPE RAT AND MOUSE MODEL MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Rat and Mouse Model Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Rat and Mouse Model Market Trends and Growth Opportunities to 2034
8.5. Europe Rat and Mouse Model Market Size Outlook by Type
8.6. Europe Rat and Mouse Model Market Size Outlook by Application
8.7. Europe Rat and Mouse Model Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Rat and Mouse Model Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Rat and Mouse Model Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Rat and Mouse Model Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Rat and Mouse Model Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Rat and Mouse Model Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Rat and Mouse Model Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Rat and Mouse Model Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Rat and Mouse Model Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Rat and Mouse Model Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Rat and Mouse Model Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Rat and Mouse Model Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Rat and Mouse Model Companies
CHAPTER 9- ASIA PACIFIC RAT AND MOUSE MODEL MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Rat and Mouse Model Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Rat and Mouse Model Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Rat and Mouse Model Market Size Outlook by Type
9.6. Asia Pacific Rat and Mouse Model Market Size Outlook by Application
9.7. Asia Pacific Rat and Mouse Model Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Rat and Mouse Model Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Rat and Mouse Model Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Rat and Mouse Model Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Rat and Mouse Model Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Rat and Mouse Model Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Rat and Mouse Model Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Rat and Mouse Model Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Rat and Mouse Model Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Rat and Mouse Model Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Rat and Mouse Model Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Rat and Mouse Model Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Rat and Mouse Model Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA RAT AND MOUSE MODEL MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Rat and Mouse Model Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Rat and Mouse Model Market Trends and Growth Opportunities to 2034
10.5. South and Central America Rat and Mouse Model Market Size Outlook by Type
10.6. South and Central America Rat and Mouse Model Market Size Outlook by Application
10.7. South and Central America Rat and Mouse Model Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Rat and Mouse Model Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Rat and Mouse Model Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Rat and Mouse Model Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Rat and Mouse Model Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Rat and Mouse Model Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Rat and Mouse Model Companies
CHAPTER 11- MIDDLE EAST AND AFRICA RAT AND MOUSE MODEL MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Rat and Mouse Model Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Rat and Mouse Model Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Rat and Mouse Model Market Size Outlook by Type
11.6. Middle East and Africa Rat and Mouse Model Market Size Outlook by Application
11.7. Middle East and Africa Rat and Mouse Model Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Rat and Mouse Model Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Rat and Mouse Model Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Rat and Mouse Model Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Rat and Mouse Model Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Rat and Mouse Model Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Rat and Mouse Model Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Rat and Mouse Model Industry
The Jackson Laboratory
Charles River Laboratories International, Inc.
Taconic Biosciences, Inc.
Envigo RMS LLC
GemPharmatech Co., Ltd.
Cyagen Biosciences
genOway
Crown Bioscience, Inc.
InVivos Pte. Ltd.
Janvier Labs
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Rat and Mouse Model Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Rat and Mouse Model Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL RAT AND MOUSE MODEL MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Rat and Mouse Model Markets in 2026
3.2. Global Historic and Forecast Rat and Mouse Model Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Rat and Mouse Model Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Rat and Mouse Model Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Rat and Mouse Model Value Chain
CHAPTER 4- RAT AND MOUSE MODEL MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Rat and Mouse Model Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- RAT AND MOUSE MODEL MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Animal Type
Mice Models
Rat Models
By Model Type
Inbred Strains
Outbred Strains
Genetically Engineered Models (GEMs)
Humanized Models
By Technology
CRISPR/Cas9
Microinjection
Embryonic Stem Cell Injection
Nuclear Transfer
By Application
Oncology
Cardiovascular and Metabolic Disorders
Neurology and Psychiatry
Immunology and Infectious Diseases
Toxicology and Safety Assessment
By End-User
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations (CROs)
Academic and Research Institutes
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA RAT AND MOUSE MODEL MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Rat and Mouse Model Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Rat and Mouse Model Market Trends and Growth Opportunities to 2034
7.5. North America Rat and Mouse Model Market Size Outlook by Type
7.6. North America Rat and Mouse Model Market Size Outlook by Application
7.7. North America Rat and Mouse Model Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Rat and Mouse Model Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Rat and Mouse Model Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Rat and Mouse Model Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Rat and Mouse Model Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Rat and Mouse Model Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Rat and Mouse Model Companies
CHAPTER 8- EUROPE RAT AND MOUSE MODEL MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Rat and Mouse Model Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Rat and Mouse Model Market Trends and Growth Opportunities to 2034
8.5. Europe Rat and Mouse Model Market Size Outlook by Type
8.6. Europe Rat and Mouse Model Market Size Outlook by Application
8.7. Europe Rat and Mouse Model Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Rat and Mouse Model Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Rat and Mouse Model Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Rat and Mouse Model Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Rat and Mouse Model Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Rat and Mouse Model Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Rat and Mouse Model Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Rat and Mouse Model Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Rat and Mouse Model Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Rat and Mouse Model Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Rat and Mouse Model Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Rat and Mouse Model Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Rat and Mouse Model Companies
CHAPTER 9- ASIA PACIFIC RAT AND MOUSE MODEL MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Rat and Mouse Model Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Rat and Mouse Model Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Rat and Mouse Model Market Size Outlook by Type
9.6. Asia Pacific Rat and Mouse Model Market Size Outlook by Application
9.7. Asia Pacific Rat and Mouse Model Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Rat and Mouse Model Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Rat and Mouse Model Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Rat and Mouse Model Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Rat and Mouse Model Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Rat and Mouse Model Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Rat and Mouse Model Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Rat and Mouse Model Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Rat and Mouse Model Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Rat and Mouse Model Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Rat and Mouse Model Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Rat and Mouse Model Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Rat and Mouse Model Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA RAT AND MOUSE MODEL MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Rat and Mouse Model Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Rat and Mouse Model Market Trends and Growth Opportunities to 2034
10.5. South and Central America Rat and Mouse Model Market Size Outlook by Type
10.6. South and Central America Rat and Mouse Model Market Size Outlook by Application
10.7. South and Central America Rat and Mouse Model Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Rat and Mouse Model Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Rat and Mouse Model Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Rat and Mouse Model Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Rat and Mouse Model Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Rat and Mouse Model Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Rat and Mouse Model Companies
CHAPTER 11- MIDDLE EAST AND AFRICA RAT AND MOUSE MODEL MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Rat and Mouse Model Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Rat and Mouse Model Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Rat and Mouse Model Market Size Outlook by Type
11.6. Middle East and Africa Rat and Mouse Model Market Size Outlook by Application
11.7. Middle East and Africa Rat and Mouse Model Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Rat and Mouse Model Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Rat and Mouse Model Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Rat and Mouse Model Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Rat and Mouse Model Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Rat and Mouse Model Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Rat and Mouse Model Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Rat and Mouse Model Industry
The Jackson Laboratory
Charles River Laboratories International, Inc.
Taconic Biosciences, Inc.
Envigo RMS LLC
GemPharmatech Co., Ltd.
Cyagen Biosciences
genOway
Crown Bioscience, Inc.
InVivos Pte. Ltd.
Janvier Labs
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
